159 related articles for article (PubMed ID: 30278937)
1. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
Yu PY; Beal EW; Hughes TM; Suarez-Kelly LP; Shelby RD; Ethun CG; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2018 Nov; 231():248-256. PubMed ID: 30278937
[TBL] [Abstract][Full Text] [Related]
2. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
Singer S; Corson JM; Demetri GD; Healey EA; Marcus K; Eberlein TJ
Ann Surg; 1995 Feb; 221(2):185-95. PubMed ID: 7857146
[TBL] [Abstract][Full Text] [Related]
5. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.
Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Le Pèchoux C; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Catton C; Casali PG; Wunder JS; Gronchi A
Eur J Cancer; 2018 Dec; 105():19-27. PubMed ID: 30384013
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
[TBL] [Abstract][Full Text] [Related]
7. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
[TBL] [Abstract][Full Text] [Related]
8. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
Movva S; von Mehren M; Ross EA; Handorf E
J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766
[TBL] [Abstract][Full Text] [Related]
10. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.
Makris EA; Tran TB; Delitto DJ; Lee B; Ethun CG; Grignol V; Harrison Howard J; Bedi M; Clark Gamblin T; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; Poultsides G; Kirane A
J Surg Oncol; 2024 Jun; 129(7):1354-1363. PubMed ID: 38562002
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of margin width for extremity and trunk sarcoma.
McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
[TBL] [Abstract][Full Text] [Related]
12. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
[TBL] [Abstract][Full Text] [Related]
13. The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC.
Acem I; van Houdt WJ; Grünhagen DJ; van der Graaf WTA; Rueten-Budde AJ; Gelderblom H; Verhoef C; ; van de Sande MAJ
Eur J Cancer; 2022 Apr; 165():71-80. PubMed ID: 35219025
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Radiation Therapy for Thoracic Soft Tissue Sarcomas: A Population-Based Analysis.
Rehmani SS; Raad W; Weber J; Lazarev S; Ayub A; Al-Ayoubi AM; Bhora FY
Ann Thorac Surg; 2020 Jan; 109(1):203-210. PubMed ID: 31520633
[TBL] [Abstract][Full Text] [Related]
15. Utilization pattern and survival outcomes of adjuvant therapies in high-grade nonretroperitoneal abdominal soft tissue sarcoma: A population-based study.
Green WR; Chokshi R; Jabbour SK; DeLaney TF; Mahmoud O
Asia Pac J Clin Oncol; 2018 Feb; 14(1):101-113. PubMed ID: 28464497
[TBL] [Abstract][Full Text] [Related]
16. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for control of soft-tissue sarcomas resected with positive margins.
Delaney TF; Kepka L; Goldberg SI; Hornicek FJ; Gebhardt MC; Yoon SS; Springfield DS; Raskin KA; Harmon DC; Kirsch DG; Mankin HJ; Rosenberg AE; Nielsen GP; Suit HD
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1460-9. PubMed ID: 17394945
[TBL] [Abstract][Full Text] [Related]
19. MRI assessment of surrounding tissues in soft-tissue sarcoma during neoadjuvant chemotherapy can help predicting response and prognosis.
Crombé A; Le Loarer F; Stoeckle E; Cousin S; Michot A; Italiano A; Buy X; Kind M
Eur J Radiol; 2018 Dec; 109():178-187. PubMed ID: 30527301
[TBL] [Abstract][Full Text] [Related]
20. The radiation dose-response of non-retroperitoneal soft tissue sarcoma with positive margins: An NCDB analysis.
Wells S; Ager B; Hitchcock YJ; Poppe MM
J Surg Oncol; 2019 Dec; 120(8):1476-1485. PubMed ID: 31710707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
